# Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

> **NCT05112692** · NA · UNKNOWN · sponsor: **Mansoura University** · enrollment: 200 (estimated)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

## Interventions

- **DRUG:** Dydrogesterone Tablets
- **DRUG:** cetrorelix 0.25mg
- **DRUG:** human menopausal gonadotropin
- **DRUG:** triptorelin 0.1 mg
- **DRUG:** human chorionic gonadotropin
- **PROCEDURE:** cryopreservation
- **DRUG:** Estradiol Valerate and progesterone

## Key facts

- **NCT ID:** NCT05112692
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11
- **Primary completion:** 2023-11
- **Final completion:** 2023-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05112692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05112692, "Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05112692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*